Navigation Links
Jury Still Out on Radiation for Early Prostate Cancer
Date:6/7/2011

By Jenifer Goodwin
HealthDay Reporter

MONDAY, June 6 (HealthDay News) -- There's too little evidence to say definitively whether treating early, localized prostate cancer with radiation is a better option than "watchful waiting," new research finds.

In a study funded by the Agency for Healthcare Research and Quality (AHRQ), researchers from Tufts University reviewed the available literature on radiation and prostate cancer, including 10 randomized controlled trials and 65 observational studies.

They concluded there was "insufficient evidence" to say with certainty whether radiation treatment compared to watchful waiting is more likely to save lives.

"We just don't have sufficient information to say much of anything," said Dr. Stanley Ip, an assistant professor of medicine at Tufts University Medical Center.

In part, that's because researchers found no randomized controlled trials -- considered the gold standard of research -- that compared radiation therapy with watching waiting, Ip said. Though there were observational studies, those may be biased because men who opt to hold off on treatment may be those whose tumors are lower risk to begin with, he said.

The study is published in the June 6 issue of the Annals of Internal Medicine.

Watchful waiting -- which does not involve cancer treatment -- means having regular exams while keeping an eye on the tumor to see if it grows or spreads. It is usually recommended when doctors feel someone's advanced age will allow them to outlive the generally slow-moving cancer or when someone has other conditions that are more likely to prove lethal.

Men who are diagnosed with early prostate cancer -- meaning it's confined to the prostate gland and has not spread -- are confronted with a bewildering array of options for treating it: surgery; radiation; drugs to deprive the tumor of the hormone androgen that may drive its growth; or watchful waiting.

In 2008, AHRQ also commissioned a review of studies on other prostate cancer treatment options, but that report could not draw conclusions on the best approach either.

"What all of these analyses have found is there is very limited data that allows us to determine which of these approaches in the best approach," said Dr. Durado Brooks, director of prostate cancer for the American Cancer Society.

Brooks said more comparative effectiveness research, which compares different kinds of treatments, is needed.

In the meantime, what are men diagnosed with early prostate cancer to do?

Men and their doctors need to consider what the tumor looks like under the microscope, which can help gauge how aggressive it may be. They should also consider age and overall health status, including whether or not the patient has other conditions more likely to cause death than the prostate cancer.

Finally, patients and their doctors should weight the potential debilitating side effects of the treatments, such as incontinence and erectile dysfunction, against how comfortable the man is with holding off on treatment, experts say.

"Men need to learn as much as they can about the possible outcomes and benefits of the various treatments and the potential side effects, and choose which direction they are most comfortable with," Brooks said.

In the current review, researchers found several trials that compared different doses of radiation and different types of radiation therapy, including external beam radiation therapy, in which a radiation is delivered through a beam through the skin, or brachytherapy, in which radioactive isotopes are delivered via injection into the prostate.

For those methods, too, there was too little research to say with confidence which method was superior in preventing deaths from prostate cancer, the researchers said. Retrospective studies, however, found that radiation treatments were associated with increased urinary or bowel problems, compared with no treatment or no initial treatment.

There was also "moderate strength evidence" that a higher external beam radiation was more effective than a lower dose.

Taken together, the review "does point out that based on current evidence, doctors should not be telling their patients that this form of radiation is better than that form," Brooks said. "Some of the distinctions being made are not really supported by the evidence."

Proton beam therapy in particular is expensive, but according to this report, there isn't enough evidence to show it's any better than other option.

Radiation, he noted, may be the best option for men whose tumors have spread outside the gland, since simply removing the prostate gland surgically is not likely to be as effective, he said.

The American Cancer Society estimates that in 2009, approximately 192,000 men were diagnosed with prostate cancer and approximately 27,000 men died of the disease.

More information

The National Cancer Institute has more on prostate cancer.

SOURCES: Stanley Ip, M.D., assistant professor, medicine, Tufts University Medical Center, Boston; Durado Brooks, M.D., director, prostate cancer, American Cancer Society, Atlanta; June 6, 2011, Annals of Internal Medicine


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Womens Heart Disease Awareness Still Lacking
2. South Carolina Attorney Says Legal Options Still Available To Those Harmed By Chantix
3. PTSD Treatment Still Lacking for Veterans
4. UAB-led study shows simple steps could reduce stillbirths by up to 1 million
5. Be Well Book Launches National Movement to Help Moms Instill Healthy Habits and End Childhood Obesity
6. As Temperature Plummets, Its Still Safe to Exercise
7. Experts call for acceleration of research and interventions for prematurity and stillbirth
8. A Small Grass-roots Non-profit, Announces That They Haven't Gone Away and are Still Alive with Helping the Disadvantaged Children in Ukraine
9. People Still Trust Their Doctors Rather Than the Internet
10. 15 years after ACL knee reconstruction, 84 percent of male patients still highly active, study says
11. Study from CWRU Nursing School finds a year after cardiac event only 37 percent still exercising
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Jury Still Out on Radiation for Early Prostate Cancer
(Date:1/17/2017)... ... January 17, 2017 , ... Anesthesia Progress – Everyone wants ... the best drug option for each patient. Dentists have several general anesthesia alternatives and ... , Researchers from the Tokyo Dental College in Tokyo, Japan wanted to find out ...
(Date:1/17/2017)... ... January 17, 2017 , ... Healthful ... , The company, owned and operated by Ed Stroup, was created to offer ... with the highest level of customer service. Healthful Balance products can be purchased ...
(Date:1/17/2017)... Clemente, CA (PRWEB) , ... January 17, 2017 ... ... Diego County, as well as Palm Desert, is opening a new office in ... Brainsway deep transcranial magnetic stimulation (dTMS) in Southern California, successfully treating individuals struggling ...
(Date:1/17/2017)... ... January 17, 2017 , ... A prescription medication bottle, pocket ... fourth Cradle to Cradle Product Design Challenge , the Cradle to Cradle ... of six circular design challenges scheduled to run through early 2018. The challenges are ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... Livionex, Inc., ... results of a double blind clinical study for its dental gel that shows significant ... national brand of toothpaste containing triclosan. The study was conducted at the Beckman Laser ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... YORK , January 18, 2017 ... of people regarding the use of cannabis both for medical ... only are more Americans open to the use of cannabis, ... financial sectors. According to Arcview Market Research, the North American ... up 30% from the previous year. The research projects sales ...
(Date:1/17/2017)... 2017 Precision medicine is an emerging ... of disease. The approach allows doctors and physicians ... The approach studies the individual profile at a ... In January 2015, Precision Medicine Initiative (PMI) was ... with more than one million volunteers. All of ...
(Date:1/17/2017)... , Jan. 17, 2017 EU5 Glucose Monitoring ... new report, "EU5 Glucose Monitoring Market Outlook to 2022", ... market. The report provides value, in millions of US ... market segments - Blood Glucose Meters, Blood Glucose Test ... shares and distribution shares data for each of these ...
Breaking Medicine Technology: